These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10722576)

  • 1. Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis.
    Wang J; Jarvis GA; Achtman M; Rosenqvist E; Michaelsen TE; Aase A; Griffiss JM
    Infect Immun; 2000 Apr; 68(4):1871-8. PubMed ID: 10722576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of human and murine monoclonal IgGs specific for the P1.7 PorA protein of Neisseria meningitidis.
    Delvig A; Jahn S; Kusecek B; Heckels JE; Rosenqvist E; Høiby EA; Michaelsen TE; Achtman M
    Mol Immunol; 1994 Nov; 31(16):1257-67. PubMed ID: 7526159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis.
    Ihle Ø; Beckstrøm KJ; Michaelsen TE
    Scand J Immunol; 2003 May; 57(5):453-62. PubMed ID: 12753502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines.
    Rouppe van der Voort EM; Kuipers B; Brugghe HF; van Unen LM; Timmermans HA; Hoogerhout P; Poolman JT
    FEMS Immunol Med Microbiol; 1997 Mar; 17(3):139-48. PubMed ID: 9093834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a murine monoclonal antibody specific for the P1.15 PorA proteins from vaccine strain B:4,7:P1.19,15 of Neisseria meningitidis.
    Pérez ME; Barberá R; Domínguez F; Otero O; Gutiérrez M; Falero-Diaz G; Sotolongo F; Sierra G
    Hybridoma (Larchmt); 2006 Aug; 25(4):243-7. PubMed ID: 16934022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.
    Suker J; Feavers IM; Maiden MCJ
    Microbiology (Reading); 1996 Jan; 142 ( Pt 1)():63-69. PubMed ID: 8581171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.
    Toropainen M; Saarinen L; van der Ley P; Kuipers B; Käyhty H
    Microb Pathog; 2001 Mar; 30(3):139-48. PubMed ID: 11273739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis.
    Michaelsen TE; Kolberg J; Aase A; Herstad TK; Høiby EA
    Scand J Immunol; 2004 Jan; 59(1):34-9. PubMed ID: 14723619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
    van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
    Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van der Ley P; van der Biezen J; George S; Tunnela O; van Dijken H; Kuipers B; Poolman J
    Infect Immun; 1996 Jul; 64(7):2745-51. PubMed ID: 8698504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes.
    Michaelsen TE; Ihle Ø; Beckstrøm KJ; Herstad TK; Kolberg J; Høiby EA; Aase A
    Infect Immun; 2003 Oct; 71(10):5714-23. PubMed ID: 14500492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van Dijken H; Kuipers B; van der Biezen J; van der Ley P; Meylis J; Claassen I; Poolman J
    Infect Immun; 1997 Dec; 65(12):5184-90. PubMed ID: 9393814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.
    McGuinness B; Barlow AK; Clarke IN; Farley JE; Anilionis A; Poolman JT; Heckels JE
    J Exp Med; 1990 Jun; 171(6):1871-82. PubMed ID: 1693651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis in outer membrane vesicles: a competitive fluorescence polarization immunoassay.
    van den Elsen JM; van Pomeren E; Poolman JT; Wilting J; Herron JN; Crommelin DJ
    Anal Biochem; 1997 May; 247(2):382-8. PubMed ID: 9177702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of an Anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design.
    Oomen CJ; Hoogerhout P; Kuipers B; Vidarsson G; van Alphen L; Gros P
    J Mol Biol; 2005 Sep; 351(5):1070-80. PubMed ID: 16038932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine.
    Martin SL; Borrow R; van der Ley P; Dawson M; Fox AJ; Cartwright KA
    Vaccine; 2000 May; 18(23):2476-81. PubMed ID: 10775781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
    Martin DR; Ruijne N; McCallum L; O'Hallahan J; Oster P
    Clin Vaccine Immunol; 2006 Apr; 13(4):486-91. PubMed ID: 16603616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.
    van der Ley P; van der Biezen J; Hohenstein P; Peeters C; Poolman JT
    Infect Immun; 1993 Oct; 61(10):4217-24. PubMed ID: 7691745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop.
    Duarte CA; Pérez L; Vázquez J; Dueñas M; Vilarrubia OL; Navea L; Valdés R; Reyes O; Montero M; Ayala M; Gavilondo J
    Immunotechnology; 1996 Feb; 2(1):11-20. PubMed ID: 9373324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.